Objective of this study was based on the formulation development of fast dispersible Aceclofenac tablets (100mg) and to evaluate the influence of pharmaceutical mixtures of directly compressible Avicel PH102 with Mannitol and Acdisol on the compressional, mechanical characteristics and drug release properties. Fifteen different aceclofenac formulations were developed by central composite rotatable design (CCRD). Among them best possible formulations (FA-FH) were selected on the basis of micromeritic properties, appropriate tablet weight and disintegration time for further study. Tablets were compressed by direct compression method using hand held hydraulic press with a compressional force ranging from 8 to 80 MN/m 2 (MPa). Pre and post compression studies were performed and the compressed formulations (FA-FH) were assessed for different quality tests. The Heckel and Kawakita equations were applied for determination of compressional behavior of formulations. The quality attributes suggested that formulation (FB) containing avicel PH 102 (20%), mannitol (25%) and ac-di-sol (3%) as best optimized formulation showing better mechanical strength i.e. hardness 37.75 ± 0.14N, tensile strength 5.67MN/m 2 and friability 0.34%. Furthermore, compressional analysis of FB showed lowest P Y value 59.52 MN/m 2 and P k value 1.040 MN/m indicating plasticity of the material. Formulation FB disintegrated rapidly within 21 seconds and released 99.92 % drug after 45min in phosphate buffer pH 6.8. Results of drug release kinetics showed that formulations FA-FH followed Weibull and First-order models in three different dissolution media. Avicel based formulation mixture exhibit excellent compactional strength with rapid disintegration and drug release.
INTRODUCTION
Advancement in tablet manufacturing technology has offered viable dosage alternatives for those patients who are facing problem related to compliance with conventional dosage forms. One such alternative dosage form is the fast dispersible tablets Fukami et al. (1) . These tablets are of two types: first type is taken in mouth without water to disintegrate rapidly or disperse readily and the second type of tablets form dispersion or solution in water to be taken by patients Schiermeier and During tablet manufacturing, compression of powder shows reduction in volume of powder bed by the application of compressional pressure in a confined space. As a result, there is formation of strong inter-particle bonds which produce a compact mass and built inherent strength in the compact to increase the overall mechanical strength of the dosage unit. This analysis is significant in understanding the behavior of poorly compactable powders during the manufacturing of the tablets Nicklasson (7).
Heckel analysis
It is one of the most widely used method to relate the reduction of powder bed volume upon application of compressional force. It is based on an assumption that "compression of powder follows first-order kinetics in which pores are reactant and powder densification is the product". It is demonstrated as follows:
Eq.1 ln [ 1 1 -ρ r ] = KP + A Graph between densification i.e. and applied pressure 'P' provides the value of 
Eq. 2 D B = D A -Do
The D A value is the final compact densification (D A = ) and it is calculated from intercept 'A' of ρ r the Heckel plot:
Kawakita analysis
Kawakita equation describes the compressional behavior of powder, either by tapping or from continuous compression experiment Kawakita and Lüdde (12). It explains the relationship between degree of volume reduction 'C' upon the application of compressional pressure 'P'. The linear expression of Kawakita equation is given below:
Where, is the initial bulk volume of the powder, is the volume of the powder after V O V P compression, 'a' is the total volume reduction for the powder bed or minimum porosity before compression and 'b' is the powder's plasticity Adetunji and colleagues (11).
The aim of the present study was to prepare fast dispersible Aceclofenac tablets and to evaluate the compressional behavior of the newly developed tablets under recommended condition of tablet manufacturing using Heckel and Kawakita analysis. Formulations were designed by Central Composite Design (CCD) using varying concentration of avicel PH102, mannitol and ac-di-sol.
All the formulations were developed by direct compression method.
MATERIALS
Aceclofenac was gifted by Sami Pharmaceutical (Pvt.) Limited. Avicel PH-102, mannitol, ac-disol, aspartame, talc and vanilla flavor were purchased from FMC Corporation, USA.
METHODS

Experimental Design
Twenty fast dispersible Aceclofenac tablet formulations (100mg) were designed with the help of Central Composite Design using Design Expert®10.0 software (Stat -Ease, Inc, Minneapolis, MN 55413, USA). The selected independent variables were avicel PH102 (20-35%), mannitol (10-25%) and ac-di-sol (1-3%). Excipients such as aspartame, vanilla flavor and talc were used at a fixed concentration i.e. 2%, 1%, and 2% respectively, composition is given in Table 1 .
Disintegration time, percentage friability and hardness of formulations were selected as the dependent variables. Response surface methodology (RSM) was used to explore the interaction of avicel PH102, mannitol and ac-di-sol to establish the appropriate amount of excipient for optimized fast dispersible formulation. On the basis of fit summary, ANOVA and multiple correlation coefficient appropriate model was selected.
Pre-Compression Studies:
Assessment of powder densities and flow Characteristics:
Bulk and tapped densities of all formulation blends were determined by pouring powder mixture in a 100 ml measuring cylinder and their initial and tapped volumes were recorded. Eq. 11
Compression of powder blends
All the ingredients were weighed and passed through 20 mesh sieve separately and mixed for six minutes (optimized mixing time) by tumbling in a polybag. After mixing all the ingredients, talc was added and mixed for further five minutes. Blends were compressed by manual filling of the die cavity. Tablets were compressed with weight ranged from 0.155 -0.212 gm by applying varied compressional pressure 7.72, 23.16, 30.88, 38.0, 46.32, 54.04, 61.76, 69.48 and 77.2 MN/m 2 ) using hand held hydraulic tableting machine (locally manufactured) fitted with pressure gauge. Tablets were stored in a desiccator for 24 h over silica gel for elastic recovery and hardening. 
Evaluation of physicochemical parameters of Aceclofenac formulations
Evaluation of Compressional Behavior
Method of applying Heckel equation
Heckel equation is used to relate the powder bed's relative density (ρ r ) to the applied pressure during compression which is the ratio of apparent density ( of the tablet and the true density (
) of powder blend:
The apparent density of tablet was calculated using the weight (g), radius (cm) and thickness ρ A (cm) of the tablet, whereas true density of the powder blend was determined by liquid displacement method (Eq. 15). 
Eq
Method of applying Kawakita equation:
Using Kawakita equation graph Vs. P is plotted and values of constants (a and b) are determined P C from slope and intercept of the plot. Reciprocal of slope is the value of 'a' (i.e. a = 1/slope) and reciprocal of the intercept yields 'ab' (i.e. ab = 1/intercept). So 'b' is calculated as:
Reciprocal of 'b' is a pressure (P K ) which reduces the thickness of powder bed by 50%.
Evaluation of In-Vitro Release behavior:
Six tablets of each test (FA-FH) and immediate release marketed (reference) formulations were placed in dissolution apparatus (USP Apparatus-II: Paddle Stirring Element) containing 900 mL of dissolution media at 37± 0.5 o C and 50 rpm.. Comparison was conducted in different dissolution media i.e. 0.1N HCl, phosphate buffer pH 4.5 and 6.8. 10 ml sample was withdrawn at 5, 10, 15, 20, 30, 45, 60, 90 and 120 min interval and substituted with fresh 10 ml of same solution. Each test and reference solutions were diluted, filtered and analyzed spectrophotometrically at 274nm
Sharma and colleagues (18) .
Release Kinetics
Model-Dependent Method
Various kinetic models were used for the evaluation of release pattern Costa and Lobo (21, Vudathala and Rogers (22) as mention in below equations:
First order kinetics
Eq. 17 logQ t = logQ 0 + k 1 t 2.303
Weibull model
Eq. 18
Higuchi model
Eq. 20 Q t = k H t 1 2
RESULTS AND DISCUSSION
The purpose of this study was to prepare fast dispersible tablets of Aceclofenac and to evaluate the effect of different concentration of avicel PH102 on the compressional behavior of newly developed formulations. Central composite design was used for designing fast dispersible formulations and composition of fifteen fast dispersible aceclofenac formulations is given in Table   1 .
Flow Properties
Powder blends of all formulations were evaluated for true, bulk and tapped densities and results were found in the range of 1. therefore, imparted negative effect on flow. Although same concentration of mannitol (25%) was present in formulations F2 and F3 but their flow was acceptable due to the presence of lesser amount of Avicel PH102. The total weight of formulations F20 was higher than the required therefore this formulations was not compressed. After micromeritic evaluation remaining formulation were subjected to compression by direct compression method using hand held hydraulic press.
Disintegration time
All formulations except F4, F12 and F14 showed acceptable disintegration time ranging from 17-45 sec. Formulations F4 and F12 contained 0.5% and 0.1% superdisintegrant respectively therefore failed to meet the disintegration time of fast dispersible tablets. Aci-di-sol in the concentration of 1.75% indicated acceptable disintegration time but the formulation F14 having same amount of superdisintegrant presented disintegration time of 4min which is beyond the requirement of fast dispersible tablets. This difference might be due to the presence of lesser concentration of mannitol (7.63%) which is hygroscopic in nature thus facilitating the process of disintegration.
On the basis of disintegration time eight formulations were selected for further evaluation. These formulations were arranged and assigned with codes for identification purpose i.e. FA-FH, presented in Table 2 . Results of micromeritic properties of selected formulation blends are shown in Table 3 . Selected formulations (FA-FH) were assessed by different quality tests and results were found to be in adequate limits. Results of different physicochemical properties of compressed tablets are shown in Table 4 .
RSM plot and ANOVA Summary
It is indicated in RSM plot that disintegration time was increased with increased concentration of avicel PH102 and mannitol, shown in Figure 1a 
Compressional behavior analysis
For evaluating compressional behavior, ten tablets from each formulation were prepared by applying different compressional pressure 7.72, 23 reported that both these compaction equations are suitable for describing the compression process of powder materials based on Avicel PH 102 (24) . Different parameters of Heckel and Kawakita equations were derived from these plots i.e. D o, D A, D B, P Y , Dl and P K and reported in Table 5 .
Heckel and Kawakita plots are presented in Figure 2 and 3 respectively.
Heckel and Kawakita equations were used to study the compressional behaviour of all formulation.
The parameters of Heckel and Kawakita equations were derived from their plots i.e. D O , D A , D B , P Y , D I and P K as mentioned in Table 4 and Figures 2 and 3 . It was reported that D O values for different aceclofenac formulations were increased as the concentration of binder was increased.
This phenomenon indicates that at die filling the initial packing of the formulations increases with the higher concentration of binder Amin and colleagues (23 (23) . Scientists also found that compaction behaviour of powder bed mostly dependent upon the deformation properties of the blends and the applied processing methods Amin and colleagues (23) . value and the highest plasticity due to the presence of highest amount of avicel PH102, whereas, formulations FG and FH showed the lowest plasticity when compressional pressure was applied (Table 5 ). It means that higher concentration of avicel PH102 rendered the tablets more plastic and thus tablet manufacturing process became easy.
Heckel analysis
Kawakita analysis
The Kawakita plot was also constructed to evaluate the compressional behavior of formulations previously reported by other researches Amin and colleagues (23) . On the other hand the P K values of these formulations were high.
It was observed in the present study that as concentration of avicel PH102 was increased the P K value was also increased (1.04 -7.69 MN/m) Formulations FE and FF had the highest P K values and FA and FB had the lowest P K values. The results of this parameter showed the elastic nature of avicel PH102 which is predominant among other excipients in the formulations. It was found from Heckel and Kawakita parameters analysis that FE and FF showed the fastest onset of plastic deformation whereas FA and FB showed maximum plastic deformation in combination with aceclofenac and other excipients. However no clear cut variation pattern of Heckel and Kawakita parameters was observed as indicated in Table 5 .
In Vitro Dissolution
In the present study in vitro drug release profiles of newly developed and optimized aceclofenac formulations were determined in different dissolution media as shown in Figure 4 (A-C). All formulations demonstrated maximum dug release in phosphate buffer pH 6.8. Different kinetic models were used to analyze the release behavior of formulations FA-FH. Results indicated that all formulations followed First-order and Weibull model in different dissolution media with highest r 2 values found in phosphate buffer pH 6.8 i.e. 0.946 -0.954 and 0.986 -0.996 respectively as shown in Table 6 .
CONCLUSION
In this study fast dispersible aceclofenac tablets were prepared and the effect of avicel PH102 was examined on compressional, mechanical and release properties of fast dispersible aceclofenac formulations. Using the Heckel and Kawakita equations, the compressional behavior was observed. The concentration of avicel PH102 exhibited a significant impact on the compressional, mechanical and release properties of the Aceclofenac fast dispersible formulations. Hence a suitable selection of excipient with appropriate concentration is important at formulation development stage to ensure stable, elegant and palatable dosage form for the patient.
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